Plunkett Research Online: Recro Pharma Inc

RECRO PHARMA INC (REPH:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Recro Pharma Inc is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that develops non-opioid products for the treatment of acute pain. The company operates two divisions Acute Care division and a contract development and manufacturing or CDMO divisio.....



Recro Pharma Inc
Ticker: REPH
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 484 395-2400
Fax: 484 395-2471
Address: 490 Lapp Road
Malvern, PA 19355 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Geraldine HenwoodCEO/Director/Founder/President
Ryan LakeCFO
See More
Recro Pharma Inc is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that develops non-opioid products for the treatment of acute pain. The company operates two divisions Acute Care division and a contract development and manufacturing or CDMO divisio.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: